BIC: Evaluation of the Current Care Processes for Stroke Care in Flemish

Status Enrolling by invitation

Clinical Trial Summary

Different studies showed large variation between care processes in multiple diseases, which lead to large variation in outcomes. Better adherence to evidence-based guidelines for these diseases can reduce this variation and can improve the health outcomes. Since international studies have demonstrated wide variations in care processes for acute stroke, it would be interesting to repeat these investigations in the population of stroke patients. Worldwide, stroke is a leading cause of disability and death. Every two seconds, someone across the world experiences a symptomatic stroke. 50% of stroke survivors has moderate to severe neurologic deficits, 25% of them depend on others. In Belgium, stroke is one of the most important causes of invalidity. Every year approximately 18 000 people in Belgium experiences a stroke, which results in almost one person every two hours, with a mortality rate of 30%. The world health organization has the ambition to significantly reduce the mortality and risk factors for non-communicable diseases by 2025. The mortality and disability in stroke patients can be reduced by organized stroke care, which includes effective strategies in stroke management, treatment and prevention. Also, other health domains, like functional recovery, healthcare costs and patient satisfaction, were positively related to adherence on stroke guidelines. This evidence had been converted in several clinical guidelines for stroke care. However, the adherence to these guidelines is variable. As already mentioned before, international studies have demonstrated wide variations in care processes for acute stroke. However, a positive relationship has been shown between the implementation of evidence-based clinical guidelines and the quality of stroke care. Therefore, it is important to both implement these guidelines and to improve the adherence to them. The aim of this study is to map the variation in stroke care in Flemish hospitals and to get an overview about the variation within and between these hospitals. During this study, electronic patient records will be analyzed to check which interventions are performed in a specific patient and of which no information could be found in de patient record.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT05218135
Study type	Observational
Source	KU Leuven
Contact
Status	Enrolling by invitation
Phase
Start date	March 1, 2021
Completion date	December 31, 2024

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT03993236` - Study on Rosuvastatin+Ezetimibe and Rosuvastatin for LDL-C Goal in Patients With Recent Ischemic Stroke	Phase 4
Completed	`NCT04069767` - Innovative Physiotherapy in Stroke Rehabilitation	N/A
Recruiting	`NCT06342206` - The Assessment of Acute /Chronic Phase in Patients With Ischemic Cerebral Stroke Using TCM Diagnostic Tools
Recruiting	`NCT03605381` - MORbidity PRevalence Estimate In StrokE
Enrolling by invitation	`NCT04956211` - Periodontal Treatment and Ischemic Stroke	N/A
Active, not recruiting	`NCT05098236` - Effect of Visual Retraining on Visual Loss Following Visual Cortical Damage	N/A
Completed	`NCT03942588` - High-intensity Interval Training After Stroke	N/A
Recruiting	`NCT04949334` - Effects of Respiratory Muscle Training in Patients With Acute Ischemic Stroke	N/A
Terminated	`NCT04095767` - Assessing Safety and Performance of the ANA Catheter System, Combined With a Stent Retriever in Acute Ischemic Stroke	N/A
Not yet recruiting	`NCT06352086` - Understanding Visual Processing After Occipital Stroke
Withdrawn	`NCT04991038` - Clinical Investigation to Compare Safety and Efficacy of DAISE and Stent Retrievers for Thrombectomy In Acute Ischemic Stroke Patients	N/A
Completed	`NCT01937182` - The Efficacy of Citalopram Treatment in Acute Stroke	Phase 2
Completed	`NCT03649295` - Combined Conventional Speech Therapy and Functional Electrical Stimulation in Dysphagia Following Stroke	N/A
Recruiting	`NCT05303649` - Effects of Neuronavigated Theta Burst Stimulation in Therapy of Post-stroke Aphasia	N/A
Completed	`NCT04233515` - Use of Oral Anticoagulants and Symptoms in Patients With Atrial Fibrillation in Örebro County
Completed	`NCT05102877` - Sensory Versus Motor Level Neuromuscular Electrical Stimulation	N/A
Completed	`NCT04089917` - A Study of the Use of the Q Aspiration Catheter to Remove Clot in Stroke Patients
Completed	`NCT05221112` - Effects of PNF Patterns Training on Trunk Balance, and Gait in Chronic Stroke Patients	N/A
Not yet recruiting	`NCT05035953` - Thrombolysis Combined With Edaravone Dexborneol on Hemorrhagic Transformation for Acute Ischemic Stroke	Phase 2
Completed	`NCT06326801` - Resistive Diaphragmatic Breathing Exercise With Pursed Lips Breathing Exercise in Sub-acute Stroke Patients	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

BIC: Evaluation of the Current Care Processes for Stroke Care in Flemish Hospitals

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms